Exact FDA event identifier

Event 80136

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: May 24, 2018
Product types: Drug
Classifications: Class I
Statuses: Terminated
Recalling firm wording: Allergan, PLC.

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Allergan Taytulla Softgel Capsules, 1 mg/20 mcg, 6x28 blister card Physicians's Sample - Not for Sale Distributed by: Allergan USA INC Irvine, CA 92612 NDC 0023-5862-28 (Blister Card) NDC 0023-5862-29 (Blister Carton) NDC 0023-5862-31 (Outer carton) UPC 300235862290

D-0875-2018

Recall number: D-0875-2018
Initiated: May 24, 2018
Classification: Class I
Status: Terminated
Recalling firm: Allergan, PLC.
Quantity: 168,768 blister cards (4,725,504 softgel capsules)

App-derived interpretation

Unknown reason.no_named_rule · v1.0.0

Contraceptive Tablets Out of Sequence.

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Contraceptive Tablets Out of Sequence.

Code information

Lot# 5620706, Exp. 05/19

Distribution pattern

US Nationwide